Improvement of the biological performance of oral anticoagulant drugs. 2. Dicumarol
Ammar, H.O.; Ghorab, M.; el-Nahhas, S.A.; Makram, T.S.
Die Pharmazie 52(9): 727-728
1997
ISSN/ISBN: 0031-7144 PMID: 9347575 Document Number: 473048
Document emailed within 1 workday
Related Documents
Biron, C.; Licznar, P.; Hansel, S.; Schved, J.F. 1999: Oral anticoagulant drugs: do not cut tablets in quarters Thrombosis and Haemostasis 82(3): 1201Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Lokossou, V.; Sombié, I.; Somé, D.Télesphore.; Dossou, C.Affoukou.; Awignan, N. 2019: Do quality improvement teams contribute to the improvement of community Health Workers' performance in Benin? Sante Publique Vol. 31(1): 165-175
Chen, Q.; Wang, X.; Yu, Y.-C.; Wei, K.-J. 2019: Effect of silencing LASP1 on biological behaviors of oral squamous cell carcinoma cells and IC50 of three anti-tumor drugs Shanghai Kou Qiang Yi Xue 28(1): 13-19
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Wynn, R.L. 2012: New antiplatelet and anticoagulant drugs General Dentistry 60(1): 8-11
Haas, S. 2005: New anticoagulant drugs: a critical perspective Current Hematology Reports 4(5): 335-338
Yamamoto, K. 2010: Anticoagulant or antiplatelet drugs and anesthesia Masui. Japanese Journal of Anesthesiology 59(9): 1160-1165
Bourde, C. 1970: Use and misuse of anticoagulant drugs in phlebitis Marseille Medical 107(12): 1009-1011
Pieper, K.; Simaitis, K. 1989: Caries prevalence, degree of cure, and oral hygiene in preschool children. 2. Improvement in oral health from 1983-1985 Deutsche Zahnarztliche Zeitschrift 44(7): 503-506
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Sellers, E.M.; Koch-Weser, J. 1972: Oral anticoagulant therapy Canadian Medical Association Journal 106(4): 302 Passim
Garr, D. 2004: Quality care and performance improvement North Carolina Medical Journal 65(6): 391
Clarke, R.; Hayduk, M. 1997: Putting it all together: clinical performance improvement Health Care Strategic Management 15(12): 1; 20-23
Blinder, D.; Martinowitz, U.; Ardekian, L.; Peleg, M.; Taicher, S. 1996: Oral surgical procedures during anticoagulant therapy Harefuah 130(10): 681
Vermeer, C. 1982: Side effects of oral anticoagulant therapy? Nederlands Tijdschrift Voor Geneeskunde 126(52): 2394
Thornes, R.D. 1974: Oral anticoagulant therapy of human cancer Journal of Medicine 5(1): 83-91
Fawcett, K.J.; Brummel, S.; Byrnes, J.J. 2009: Restructuring primary care for performance improvement Journal of Medical Practice Management: Mpm 25(1): 49-56
Hill, S.A. 2002: Performance improvement in the JCAHO environment of care Journal of Healthcare Protection Management: Publication of the International Association for Hospital Security 18(1): 30-33